» Articles » PMID: 27477292

Diabetes Mellitus As a Risk Factor for Incident Chronic Kidney Disease and End-stage Renal Disease in Women Compared with Men: a Systematic Review and Meta-analysis

Overview
Journal Endocrine
Specialty Endocrinology
Date 2016 Aug 2
PMID 27477292
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes mellitus is a strong risk factor for chronic kidney disease and end-stage renal disease. Whether sex differences in chronic kidney disease and end-stage renal disease incidence exist among diabetic patients remains unclear. This systematic review and meta-analysis was conducted to evaluate the relative effect of diabetes on chronic kidney disease and end-stage renal disease risk in women compared with men. We systematically searched Embase, PubMed, and the Cochrane Library for both cohort and case-control studies until October 2015. Studies were selected if they reported a sex-specific relationship between diabetes mellitus and chronic kidney disease or end-stage renal disease. We generated pooled estimates across studies using random-effects meta-analysis after log transformation with inverse variance weighting. Ten studies with data from more than 5 million participants were included. The pooled adjusted risk ratio of chronic kidney disease associated with diabetes mellitus was 3.34 (95 % CI 2.27, 4.93) in women and 2.84 (95 % CI 1.73, 4.68) in men. The data showed no difference in diabetes-related chronic kidney disease risk between the sexes (pooled adjusted women-to-men relative risk ratio was 1.14 [95 % CI 0.97, 1.34]) except for end-stage renal disease-the pooled adjusted women-to men relative risk ratio was 1.38 (95 % CI 1.22, 1.55; p = 0.114, I² = 38.1 %). The study found no evidence of a sex difference in the association between diabetes mellitus and chronic kidney disease. However, the excess risk for end-stage renal disease was higher in women with diabetes than in men with the same condition, from which we assume that the female gender could accelerate the disease progression. Further studies are needed to support this notion and elucidate the underlying mechanisms.

Citing Articles

The role of advanced glycation end products between thyroid function and diabetic nephropathy and metabolic disorders.

Zhang Y, Wang Y, Kang Q, Chen Y, Ai L, Hu K Sci Rep. 2025; 15(1):7202.

PMID: 40021692 PMC: 11871035. DOI: 10.1038/s41598-025-88806-7.


Plant-Dominant Low-Protein Diets: A Promising Dietary Strategy for Mitigating Disease Progression in People with Chronic Kidney Disease-A Comprehensive Review.

Kaimori J, Sakaguchi Y, Oka T, Isaka Y Nutrients. 2025; 17(4).

PMID: 40004970 PMC: 11857991. DOI: 10.3390/nu17040643.


The Asia-Pacific Body Mass Index Classification and New-Onset Chronic Kidney Disease in Non-Diabetic Japanese Adults: A Community-Based Longitudinal Study from 1998 to 2023.

Okawa Y, Mitsuhashi T, Tsuda T Biomedicines. 2025; 13(2).

PMID: 40002785 PMC: 11853003. DOI: 10.3390/biomedicines13020373.


Global burden of chronic kidney disease due to dietary factors.

Yin L, Kuai M, Liu Z, Zou B, Wu P Front Nutr. 2025; 11:1522555.

PMID: 39882042 PMC: 11774714. DOI: 10.3389/fnut.2024.1522555.


Longitudinal trend in post-discharge estimated glomerular filtration rate in intensive care survivors.

Glendell R, Puxty K, Shaw M, Sim M, Traynor J, Mark P J Intensive Care Soc. 2024; 26(1):29-37.

PMID: 39734804 PMC: 11670225. DOI: 10.1177/17511437241308673.


References
1.
Mankhey R, Bhatti F, Maric C . 17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol. 2004; 288(2):F399-405. DOI: 10.1152/ajprenal.00195.2004. View

2.
Mankhey R, Wells C, Bhatti F, Maric C . 17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am J Physiol Regul Integr Comp Physiol. 2006; 292(2):R769-77. DOI: 10.1152/ajpregu.00375.2006. View

3.
Yu M, Lyles C, Bent-Shaw L, Young B . Risk factor, age and sex differences in chronic kidney disease prevalence in a diabetic cohort: the pathways study. Am J Nephrol. 2012; 36(3):245-51. PMC: 3510352. DOI: 10.1159/000342210. View

4.
Neugarten J, Acharya A, Silbiger S . Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000; 11(2):319-329. DOI: 10.1681/ASN.V112319. View

5.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View